A prospective study about efficacy and safety of selective arterial injection chemotherapy for ineffective or intorelable to the standard chemotherapy in advanced esophageal cancer

A prospective study about efficacy and safety of selective arterial injection chemotherapy for ineffective or intorelable to the standard chemotherapy in advanced esophageal cancer - A prospective study of selective arterial injection chemotherapy for limited advanced esophageal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028542

Enrollment

Registered

2017-08-05

Start date

2017-08-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagus

Interventions

selective arterial injection chemotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Neoadjuvant chemotherapy for advanced esophageal cancer 2)Cases of ineffective for first FP chemotherapy(SD,PD) 3)Cases of intolerable for other therapies 4)Cases of impossible for other therapies

Exclusion criteria

Exclusion criteria: 1)Impossible for catheter treatment 2)below 20 years old 3)pregnant 4)No informed consent 5)Inappreciate patients

Design outcomes

Primary

Measure	Time frame
Tumor regression effect	—

Countries

Japan

Contacts

Public ContactManabu Onimaru

Showa University Koto Toyosu Hospital Digestive Diseases Center

mnbonmr0827@gmail.com03-6204-6000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026